Clinical Research Directory
Browse clinical research sites, groups, and studies.
PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France
Sponsor: Phenox GmbH
Summary
To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.
Official title: CEFloW (Clinical Experience With Flow Diverter With and Without Movable Wire)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-03-07
Completion Date
2028-12
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
Aneurysm treatment with a Flow Modulation Device
Treatment of an intracranial aneurysm (anterior and posterior circulation) with a p64, p48 MW, or p64 MW Flow Modulation Device.
Locations (11)
CHU Amiens-Picardie
Amiens, France
CHU Bordeaux
Bordeaux, France
CHU Pierre Wertheimer
Bron, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
CHU de Limoges
Limoges, France
Hôpital Pitié-Salpêtrière
Paris, France
CHU Reims
Reims, France
CHU Rouen
Rouen, France
CHRU Strasbourg
Strasbourg, France
CHU Tours
Tours, France